Here are three things to know.
- Hereditary angiodema is a rare, inherited blood disorder where the body does not make enough plasma protein called C1-esterase inhibitor. The disease can cause rapid swelling attacks of the limbs, face, intestinal tract and airway.
- CSL Behring’s drug, Haegarda, is the first self-administered C1 esterase inhibitor injected under the skin to prevent these swelling attacks before they occur.
- Haegarda contains a freeze-dried version of the plasma protein, derived from the plasma of U.S. organ donors.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
